FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Somatropin Recombinant (Humatrope) Injection
Status: Discontinuation
»Therapeutic Categories: Hematology

Eli Lilly and Co. (New 07/07/2020)

Company Contact Information:

Presentation Posting Date Related Information
5 mg kit (NDC 0002-7335-11) contains 5 mg/mL in 1 vial (NDC 0002-7349-01) of Humatrope and 5 mL in 1 vial (NDC 0002-7336-01) of Sterile Diluent 07/07/2020 Other Somatropin Recombinant (Humatrope) Injection products will continue to be available to treat patients. The product distribution will continue until end of December 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English